Lake Hills Wealth Management’s Charles River Laboratories CRL Stock Holding History

Lake Hills Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$746K	Buy	+2,528	New	+$666K	0.34%	42

Other funds holding CRL

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Lake Hills Wealth Management's CRL Position: Q3 2026 in Review

Lake Hills Wealth Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 2,528 shares worth $746K. The stake represents 0.34% of the portfolio and ranks #42 among its holdings.

15 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

Lake Hills Wealth Management held 2,528 shares of Charles River Laboratories worth $746K as of Q3 2026.
Charles River Laboratories was a new Lake Hills Wealth Management position in Q3 2026.
Charles River Laboratories made up 0.34% of Lake Hills Wealth Management's portfolio in Q3 2026, its #42 holding.
15 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Lake Hills Wealth Management's 13F filing for Q3 2026, filed 7 Oct 2026.